Jeremy Pomeroy to Obesity
This is a "connection" page, showing publications Jeremy Pomeroy has written about Obesity.
Connection Strength
0.710
-
Cabre HE, Drews KL, Pomeroy J, Keadle SK, Arteaga SS, Franks PW, Haire-Joshu D, Knowler WC, Pi-Sunyer X, Van Horn L, Wing RR, Cahill AG, Clifton RG, Couch KA, Gallager D, Josefson JL, Joshipura K, Klein S, Martin CK, Peaceman AM, Phelan S, Thom EA, Redman LM. LIFE-Moms: effects of multicomponent lifestyle randomized control trial on physical activity during pregnancy in women with overweight and obesity. Int J Behav Nutr Phys Act. 2025 Sep 30; 22(1):119.
Score: 0.129
-
Lazareva J, Sisley SR, Brady SM, Smith ACM, Elsea SH, Pomeroy JJ, Roth CL, Sprague JE, Wabitsch M, Garrison J, Yanovski JA. Investigation of setmelanotide, an MC4R agonist, for obesity in individuals with Smith-Magenis syndrome. Obes Res Clin Pract. 2024 Jul-Aug; 18(4):301-307.
Score: 0.119
-
Pomeroy J, Offenwanger KM, Timmler T. Diabetes mellitus in Bardet Biedl syndrome. Curr Opin Endocrinol Diabetes Obes. 2023 02 01; 30(1):27-31.
Score: 0.106
-
Pomeroy J, VanWormer JJ, Meilahn JR, Maki T, Murali HR, Haws RM. Sleep and physical activity patterns in adults and children with Bardet-Biedl syndrome. Orphanet J Rare Dis. 2021 06 14; 16(1):276.
Score: 0.096
-
VanWormer JJ, Kieke BA, Hanrahan LP, Pomeroy JJ, Mundy A, Schoeller DA. Circannual growth in Wisconsin children and adolescents: Identifying optimal periods of obesity prevention. Pediatr Obes. 2020 01; 15(1):e12572.
Score: 0.085
-
Argente J, Haqq AM, Schorfheide JL, Touchot N, Huber C, Wiedemann U, Pomeroy J. Setmelanotide in Bardet-Biedl Syndrome: A 52-Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort. Obesity (Silver Spring). 2026 Mar; 34(3):579-587.
Score: 0.033
-
Forsythe E, Mallya UG, Yang M, Huber C, Cala ML, Greatsinger A, Hagopian E, Pomeroy J, Haqq AM. Burden of hyperphagia and obesity in Bardet-Biedl syndrome: a multicountry survey. Orphanet J Rare Dis. 2023 07 07; 18(1):182.
Score: 0.028
-
Forsythe E, Mallya UG, Yang M, Huber C, Cala ML, Greatsinger A, Hagopian E, Pomeroy J, Haqq AM. Caregiver burden in Bardet-Biedl syndrome: findings from the CARE-BBS study. Orphanet J Rare Dis. 2023 07 07; 18(1):181.
Score: 0.028
-
Boyer BB, Wiener HW, Hopkins SE, Purnell JQ, O'Brien DM, Aliwarga T, Pomeroy JJ, Aslan JE, Thummel KE, Tiwari HK. Obesity-Associated Dyslipidemia Is Moderated by Habitual Intake of Marine-Derived n-3 Polyunsaturated Fatty Acids in Yup'ik Alaska Native People: A Cross-Sectional Mediation-Moderation Analysis. J Nutr. 2023 01; 153(1):279-292.
Score: 0.027
-
Phelan S, Marquez F, Redman LM, Arteaga S, Clifton R, Grice BA, Haire-Joshu D, Martin CK, Myers CA, Pomeroy J, Vincent E, Van Horn L, Peaceman A, Ashby-Thompson M, Gallagher D, Pi-Sunyer X, Boekhoudt T, Drews K, Brown G. The moderating role of the built environment in prenatal lifestyle interventions. Int J Obes (Lond). 2021 06; 45(6):1357-1361.
Score: 0.024
-
Martin CL, Tate DF, Schaffner A, Brannen A, Hatley KE, Diamond M, Munoz-Christian K, Pomeroy J, Sanchez T, Mercado A, Hagobian T, Phelan S. Acculturation Influences Postpartum Eating, Activity, and Weight Retention in Low-Income Hispanic Women. J Womens Health (Larchmt). 2017 12; 26(12):1333-1339.
Score: 0.018
-
Clifton RG, Evans M, Cahill AG, Franks PW, Gallagher D, Phelan S, Pomeroy J, Redman LM, Van Horn L. Design of lifestyle intervention trials to prevent excessive gestational weight gain in women with overweight or obesity. Obesity (Silver Spring). 2016 02; 24(2):305-13.
Score: 0.016